Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DOT1L | Q8TEK3 | 8/20 | 0.73 |
| ▸ | EZH2 | Q15910 | 5/20 | 0.73 |
| ▸ | CARM1 | Q86X55 | 3/20 | 0.73 |
| ▸ | EHMT2 | Q96KQ7 | 3/20 | 0.73 |
| ▸ | NNMT | P40261 | 3/20 | 0.73 |
| ▸ | NSD2 | O96028 | 3/20 | 0.73 |
| ▸ | SETD7 | Q8WTS6 | 3/20 | 0.73 |
| ▸ | PRMT1 | Q99873 | 3/20 | 0.73 |
| ▸ | DNMT1 | P26358 | 3/20 | 0.73 |
| ▸ | HNMT | P50135 | 2/20 | 0.73 |
| ▸ | TRDMT1 | O14717 | 2/20 | 0.73 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.73 |
| ▸ | INMT | O95050 | 2/20 | 0.73 |
| ▸ | METTL3 | Q86U44 | 2/20 | 0.73 |
| ▸ | EHMT1 | Q9H9B1 | 2/20 | 0.73 |
| ▸ | METTL14 | Q9HCE5 | 2/20 | 0.73 |
| ▸ | FASN | P49327 | 2/20 | 0.73 |
| ▸ | DNMT3B | Q9UBC3 | 2/20 | 0.73 |
| ▸ | SUV39H1 | O43463 | 1/20 | 0.73 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14174632 | 1.00 | DOT1L (0.73) | DOT1LEZH2CARM1EHMT2NNMT | |
| SCHEMBL19245152 | 0.91 | DOT1L (0.60) | DOT1LEZH2CARM1EHMT2NNMT | |
| SCHEMBL19245155 | 0.90 | DOT1L (0.59) | DOT1LEZH2CARM1EHMT2NNMT | |
| SCHEMBL19245156 | 0.87 | DNMT1 (0.74) | DOT1LEZH2CARM1EHMT2NNMT | |
| SCHEMBL14174715 | 0.87 | DNMT1 (0.73) | DOT1LEZH2CARM1EHMT2NNMT | |
| S-Adenosylhomocysteine SCHEMBL13073142 | 0.84 | DOT1L (1.00) | DOT1LEZH2CARM1EHMT2NNMT | |
| S-Adenosylhomocysteine SCHEMBL18826562 | 0.84 | DOT1L (1.00) | DOT1LEZH2CARM1EHMT2NNMT | |
| S-Adenosylhomocysteine SCHEMBL17316165 | 0.84 | DOT1L (1.00) | DOT1LEZH2CARM1EHMT2NNMT | |
| S-Adenosylhomocysteine SCHEMBL13033864 | 0.84 | DOT1L (1.00) | DOT1LEZH2CARM1EHMT2NNMT | |
| S-Adenosylhomocysteine SCHEMBL21160481 | 0.84 | DOT1L (1.00) | DOT1LEZH2CARM1EHMT2NNMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0414730-B1 | Chemical Compounds and pharmaceutical compositions capable of releasing a drug | MILLS RANDELL L (US) | 1999-12-15 | — | — | EP | claimed |
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | LUMINIDE | 2005-04-14 | — | — | US | disclosed |
| EP-0414730-B1 | Chemical Compounds and pharmaceutical compositions capable of releasing a drug | MILLS RANDELL L (US) | 1999-12-15 | — | — | EP | disclosed |
| US-5773592-A | COMPRISES A CHEMILUMINESCENT MOIETY, A PHOTOCHROMIC MOIETY AND A BIOLOGICALLY ACTIVE AGENT CAPABLE OF BEING RELEASED | MILLS RANDELL LEE (US) | 1998-06-30 | — | — | US | disclosed |
| US-5428163-A | Luminides; chemiluminescence; redox system, releasing free drug | MILLS RANDELL L (US) | 1995-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | APEH, PAH, ALAD | DOT1L 2368/4885EZH2 2164/4885CARM1 3323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.